We have completed production in rabbits of potent antisera to the 90 classified rhinovirus serotypes by using methods previously described (M. K. Cooney and G. E. Kenny, Proc. Soc. Exp. Biol. Med. 133:645-650, 1970). Systematic testing by neutralization tests has revealed significant numbers of cross-relationships among rhinovirus types, some of which have already been reported. Herein, our observations are compared with cross-reactions reported in National Institutes of Health reference guinea pig antisera. Also, original rhinovirus isolates, representing serotypes known to be antigenically related to other rhinoviruses, were tested against rabbit antisera to the related serotypes. These tests revealed extensive antigenic variation among isolates identified as rhinovirus 12:78 or 36:58, which are reciprocally related pairs, 41, reciprocally related to 13, and 67, which is related to both 9 and 32. If the rhinovirus serotypes were grouped according to antigenic relationships, 50 types could be included in 16 groups.
When the numbering scheme for rhinoviruses 1 through 55 was published, only type 1 was assigned subtypes A and B; all others were assumed to be distinct serotypes, and no subtypes were identified in types 56 through 89 (2, 3). We and others have shown that there are relationships between many rhinovirus types as demonstrated by one-way and reciprocal crossreactions shown by neutralization. Some of these relationships involve three different serotypes. Rhinovirus typing is a very cumbersome procedure, not only because of the large number of serotypes (at least 115 exist), but also because many serotypes circulate concurrently in the community, which means that each isolate must be tested against all antisera. Thus, even when combinatorial pools (13) are used for typing, antigenic variation in field strains presents a problem in typing. For example, a variant of 12:78 could be neutralized by the two pools containing anti-12 and the one pool containing 78, producing a pattern which does not identify any specific type.
We have examined the cross-relationships among rhinoviruses as revealed by neutralizing antibody in our rabbit antisera and similar reactions reported in reference guinea pig sera. We suggest a scheme for grouping antigenically related types which would include all serotypes related to any member of the group. This would reduce the number of serotypes and could form a basis for constructing antiserum pools to include related types in one pool, thus facilitating typing by reenforcing the neutralization reaction and eliminating problems in typing field isolates which are intermediate between two related types.
MATERIALS AND METHODS Methods for preparation of rhinovirus immunogens (5) , immunization of rabbits (6, 7) , and antibody titrations in microtiter plates have been described in previous publications. Slight modifications of some procedures were introduced.
Preparation of rhinovirus immunogens. Seed virus for each prototype rhinovirus serotype was obtained from V. V. Hamparian, Ohio State University. Seed virus stocks were plaque purified in M-HeLa plates (12) , and the serotype was confirmed with reference antiserum (9) . HeLa cell monolayers in roller bottles were infected at a multiplicity of infection of 10. Infected cells were harvested in a reduced volume of cell culture medium. Cells were homogenized to effect virus release, and the homogenate was centrifuged to remove cell debris. The supernatant, after extraction with fluorocarbon to remove nonviral antigens, constituted the immunogen and contained at least 107 plaque-forming units per ml.
Immunization schedule for rabbits. The serotype of the immunogen was again confirmed before a pair of rabbits was injected with each preparation. A preimmunization blood sample was collected, and each rabbit received an intramuscular injection of 2 ml of immunogen mixed with 2 ml of Freund incomplete adjuvant (1 ml at each of four sites).
After 21 days, 0.1 ml of immunogen without adjuvant was injected intravenously, followed at 3-day intervals by intravenous injections of 0.2, 0.3, and 0.4 ml. Rabbits were bled out by cardiac puncture 7 days after the final intravenous injection.
Neutralizing antibody titrations. Appropriate twofold serum dilutions (1:10 to 1:160 for pre-immunization sera and 1:10 to 1:5,120 for post-immunization sera) were prepared in quadruplicate in flat-bottomed, (14) . Neutralizing antibody titers in guinea pig sera are those reported in the NIAID Catalog ofResearch Reagents (9) .
Determination of k values. In rabbit sera that neutralized heterotypic rhinovirus, neutralization rate constants (k) were determined to assess the quality of the homologous antibody and to verify the specificity of heterologous response. Equal volumes of antisera (diluted 1:500 or 1:1,000 for homologous virus and 1:20 for heterologous virus) and virus (10' plaque-forming units per ml) were mixed and incubated in a water bath at 37°C. Samples of the homologous system were removed at 2, 5, 10, and 15 min, diluted 1:100 in cold diluent, and held in an ice bath until plated. The heterologous system was sampled at 10, 15, 20, and 30 min. The virus control was sampled at 0, 15, and 30 min. Plaque assays were performed on all samples in HeLa plates with 30 mM Mg2l in the medium as previously described (12) . Neutralization rate constants were calculated by the equation: k = 2.3 x (D/t) x log (VJV,), where D is the reciprocal of final dilution of serum in serum-virus mixture, t is the time (minutes), VO is the plaque-forming units at time 0, and V, is the plaque-forming units at time t (1).
RESULTS
Titration of the antisera from individual rabbits against each homotypic rhinovirus revealed 50%o endpoint neutralization titers ranging from 1,000 to 5,000 in most cases. If homotypic antibody titers were lower than 512, a second pair of rabbits was immunized in the hope of obtaining more potent antisera. Since we intended to use the antisera in pools for typing isolates, it was important to have a high titer and also to assure specificity. A 1:20 dilution of each rabbit antiserum was tested against 30 to 300 doses of the 89 heterotypic rhinoviruses (1A and 1B are considered as two serotypes, for a total of 90).
Sera that neutralized any heterotypic rhinoviruses at 1:20 were titrated for serum neutralization endpoints against those viruses. Many of the cross-reactions have been published previously (6, 8) , and sera showed antibody to two types, and 1, antirhinovirus 30, neutralized three heterotypic viruses. The antigenic cross-relationships involved 26 rhinovirus types, 13 of which were not involved in cross-reactions when tested with the rabbit antisera.
Although antibody to rhinovirus 1B was not seen in antirhinovirus 1A guinea pig serum, the titer against rhinovirus 1A, 1,280 in anti-lB serum, was almost identical to the homologous titer, 1,600. In other sera, the heterotypic titers ranged from 20 to 160, with a median titer of 40 and a mean of 63. Several cross-relationships were seen in both the guinea pig reference antisera (Table 2 ) and the rabbit antisera (Table  1) b Antisera raised in rabbits against prototype rhinovirus strains for use in typing isolates.
' Prototype rhinovirus strains used as antigen in the production of rabbit antisera. 9 or -32 at a 1:20 dilution, one was neutralized by anti-32 only, and one was neutralized by both diluted 1:40. Depending on the distribution of antisera in the typing pools, the isolate might be neutralized by three or four pools, thus necessitating testing the isolate against as many as 40 individual antisera to identify it.
Measurements of neutralization rate constants (k values) provide a measure of affinity and avidity, or "quality," of the antibody. The k value determination also precludes the false appearance of neutralization of virus due to cytotoxic effects of the antiserum (4). Therefore, the k value confirms the evidence for antigenic relatedness demonstrated by cross-neutralization. Table 4 Table 2 ). In addition, a relaz tionship between rhinovirus types 2 and 49 was indicated which has previously been reported (7, 11, 15) , as well as a relationship between types 36 and 58 in rabbit sera, included in the present . = report.
The use of different animals, rabbits and guinea pigs, is the most obvious source of differences 00 in results. Other differences must be considered o and probably have a significant influence on x0 results. Immunogens used for rabbits were produced in HeLa cells in such a way as to produce a maximum yield of virus. These preparations, The guinea pig reference antisera are designed to neutralize only homotypic virus when tested at a level of 20 antibody units against prototype strains of rhinovirus, and they meet this stipulation. However, it is antigenic variation among strains isolated from field studies which presents a problem in the use of antirhinovirus serum pools. The rhinovirus 22 "prime" strain of Schieble et al. (17) , for example, is a duplicate of the response in guinea pigs to IA and 1B, in which 1B antigen elicits essentially equal response to 1A and IB, whereas anti-lA serum does not neutralize 1B. Previous practice would dictate that the prime strain should be used as antigen for production of typing serum. Stott and Walker (18) investigated a number of rhinovirus isolates typed as 51 and found a range of variation, from a minor cross-reaction to identity with the prototype. Similar variation was seen in our laboratories (Table 3) , particularly in strains of 36:58 and 78:12. Strains of 41 (related to 13) and 67 (related to 9 and 32) showed variation in cross-reacting antigen but were type identified by antisera to prototype virus included in the typing pools. Some strains of rhinovirus 12 or 78 were neutralized by a high dilution of antirhinovirus 12 or 78. Several strains were neutralized by both antisera, but at much lower dilutions than either prototype virus. These strains are obviously different from rhinovirus 12 or 78 and probably represent a subtype of the rhinovirus 12:78 "group." Antisera to selected isolates are being prepared to further explore the relationship. Mogabgab et al. (15) (10, 15) . It is possible that previously existing antibody in the infected person may cause antigenic changes in virus.
The recently discovered existence of dual rhinovirus infection (6) on September 29, 2017 by guest http://iai.asm.org/ Downloaded from variation in field strains is greatly facilitated by examining those isolates which are related to two or more rhinovirus serotypes.
Existing "monospecific" antisera are generally useful for typing rhinoviruses according to the present classification and will also be useful in exploring possibilities for consolidation and simplification of the system. It is apparent that any hope for control of rhinovirus infections depends on the ability to isolate and identify these agents. Consolidation of the classification system, even to the extent suggested here, should make identification more feasible.
